Oxidized LDL is the atherogenic form of LDL, directly involved in the initiation and progression of the atherosclerotic disease process.
A Biomarker for subclinical development of atherosclerosis.
Strongest predictor of future Coronary Heart Disease events.
Powerful tool in assessing Metabolic Syndrome risk.
This OxLDL ELISA is based on the highly specific monoclonal antibody.
Elevated OxLDL levels correlate stronger with cardiovascular diseases than LDL-cholesterol.
(Johnston et al. (2006) Am J Cardiol 97:640-645.)